Palisade Bio (PALI) Accumulated Expenses (2010 - 2026)

Palisade Bio (PALI) has reported Accumulated Expenses for 16 consecutive years, with $122000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Accumulated Expenses rose 3.39% year-over-year to $122000.0; the TTM figure through Mar 2026 stood at $122000.0 (up 3.39% YoY), while the FY2025 annual figure was $1.3 million, up 79.78% from the prior year.
• Accumulated Expenses fell to $122000.0 in Q1 2026 per PALI's latest filing, from $1.3 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.3 million in Q4 2025 and bottomed at $72000.0 in Q1 2022.
• Historically, Accumulated Expenses has averaged $417941.2 across 5 years, with a median of $309000.0 in 2023.
• Annual changes were most pronounced in 2022 — Accumulated Expenses slumped 73.75% — and 2023, when it jumped 686.84%.
• Palisade Bio's Accumulated Expenses stood at $574000.0 in 2022, then jumped by 44.77% to $831000.0 in 2023, then declined by 13.12% to $722000.0 in 2024, then jumped by 79.78% to $1.3 million in 2025, then slumped by 90.6% to $122000.0 in 2026.
• Business Quant data shows PALI's Accumulated Expenses at $122000.0 in Q1 2026, $1.3 million in Q4 2025, and $621000.0 in Q3 2025.